Microsurgery Articles & Analysis
49 news found
An innovative Australian micro screw created to help significantly reduce complications in the management of orthopaedic injuries and the fixing of fractures in the hand and wrist will be used in a world-first operation in Brisbane by internationally-renowned hand surgeon Dr Greg Couzens on Wednesday 30 January. The Field Micro Screw by Brisbane med-tech start-up Field Orthopaedics has already ...
Maria is an associate professor, senior lecturer and director of the plastic and reconstructive microsurgery department at the Uppsala University Hospital. ...
Update: After a year of absence due to the pandemic, the World Society of Reconstructive Microsurgery could celebrate its 11th Congress in Cancun from 1-4 June 2022. ...
CO2 fractional laser resurfacing machine treatment can quickly improve skin texture, firm skin, improve large pores, and make skin smooth and tender like water. CO2 fractional laser technology is now the world's leading technology for wrinkle removal and skin rejuvenation. Through pulsed fractional laser, laser beauty has been raised to a new level. Bvlaser is a professional CO2 fractional laser ...
HIFU is the abbreviation of high intensity focused ultrasound. It uses focused ultrasound energy to accurately inject the dermis, subcutaneous tissue, and SMAS (facial superficial aponeurotic system) fascia layer of the skin to increase the temperature of the target site and initiate collagen regeneration and firming. There are two keys to HIFU skin tightening machine treatment: depth and ...
(MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the launch of its new Supermicro NanoWrist® instruments for use with the Symani® Surgical System, developed specifically to address the challenges of microsurgery. ...
(MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced it has raised $75 million in Series B financing. ...
Metropolitan Region Eindhoven (MRE) provides a stimulus grant to support a new development program between Microsure and MTA. With the funding, MUSA-3, a new generation microsurgical robot will be developed where safety, usability, dexterity and ergonomics will be improved. We are very pleased that with the financial support from the region, our long-standing collaboration can be ...
The technology is cleared for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive and microsurgeries. OnLume is developing further applications of its imaging platform, including FGS for cancer surgery, in which tumor-specific drugs could deliver fluorescent dye to cancer cells to ...
The technology is cleared for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive and microsurgeries. OnLume is expanding clinical indications of its imaging platform to help identify critical anatomy in real time during surgery that is otherwise invisible to ...
OnLume has received 510(k) clearance from the U.S. Food & Drug Administration (“FDA”) to market its first product, a fluorescence guided surgery (FGS) system. The OnLume Imaging System is indicated for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive, and micro surgeries. This ...
Microsure and Olympus teamed up in the world’s first case in plastic surgery in which robotic microsurgery was combined with their newest digital exoscope. Microsure’s MUSA and the Olympus OrbEye 3D 4K camera were used during a clinical case. With this set-up the surgeon is able to do so-called “heads up microsurgery”, which means the ...
June 8.2022 - Medical Microinstruments (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced that it will participate in "THE MINIMALLY INVASIVE ROBOTIC SURGERY SYSTEMS project (TREMIRS). ...
Milan, Italy (June 1st, 2022) – Today, KLISBio, a MedTech company challenging the status quo in regenerative medicine by leveraging a silk-based multidisciplinary technology platform, announced its attendance to 2022 IFSSH, IFSHT & FESSH Combined Congress organized by the International Federation of Societies for Surgery of the Hand and International Federation of Societies for Hand ...
ByKLISBio
PISA, Italy, May 26,2022 - Medical Microinstruments (MMI) SpA. a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the launch of its Symani Surgical System Simulator developed by VirtaMed. ...
PISA, Italy, May 18, 2022 - Medical Microinstruments (MMI) SpA. a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the grand opening of its new facility in Pisa, Italy. ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has commenced a Phase 2 clinical program for its third-generationiLink™ therapy designed to treat keratoconus. ...
Lightpoint Medical today announced that Dr. Doug Adams, a specialist in robotic thoracic surgery at Bethesda North Hospital (part of TriHealth, Ohio) performed a first-in-the-world lung procedure with SENSEI, the company's new miniature robotic gamma probe. SENSEI is smaller than an AA battery and designed specifically for robotic and minimally-invasive surgery. The miniature size and ...
“Our strategic partnership with some of the most respected and knowledgeable local and regional tech investors in Europe will accelerate our growth in this critical market.” Microsurgery is characterized by performing surgery close to the limits of what is physically possible. ...
Approximately 70% of Subjects were Well-Controlled on iDose TR with the Same or Fewer Topical IOP-Lowering Medications at 36 Months vs. Screening Favorable Safety Profile Through 36 Months . SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...